The Valley Desk

Clinical trial reportNature medicinePublished

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

12 of 32 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Nature medicine
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm, Residual; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Antibodies, Monoclonal; Treatment Outcome; Adult; Aged; Middle Aged; Female; Male
PubMed ID
42350642
PubMed Central ID
PMC13375549
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal